You are here: Home » News-CM » Companies » News
Business Standard

Indoco Remedies receives ANDA approval for Apixaban Tablets

Capital Market 

Indoco Remedies announced receipt of approval for its ANDA for Apixaban Tablets 2.5mg & 5mg.

The products are therapeutically equivalent to the Reference Listed Drug 'Eliquis' of Bristol-Myers Squibb (BMS).

Apixaban is an anticoagulant, or blood thinner. It is used for patients with health problems caused by a blood clot.

The US market size of Apixaban Tablets is USD 11,037 million as per IMS MAT June'20 data.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, September 14 2020. 09:26 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU